Werner Risau - Concepedia

Author

Werner Risau

Max Planck Institute for Heart and Lung Research

Also Known As

Risau, W, Risau, Werner, Takahiro Kunisada, W RISAU, W Risau, W. RISAU, W. Risau, WERNER RISAU, Werner RISAU, Werner Risau

175

Publications

46.8K

Citations

H-Index

134

Concepts

All Affiliations

Max Planck Institute for Heart and Lung Research Max Planck Society Max Planck Institute of Psychiatry Max Planck Institute of Biochemistry University of Tübingen

About

Werner Risau is an author at Max Planck Institute for Heart and Lung Research specializing in medicine, vascular biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	60	79	27.8K
2	Health Sciences	21	23	6.7K
3	Natural Sciences	10	10	1.3K
4	Social Sciences	6	6	1.1K
5	Engineering	3	3	167

Werner Risau

120

Publications

37.5K

Citations

H-Index

Page 1

	Year	Citations
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele Peter Carmeliet, Valérie Ferreira, Georg Breier, Nature Developmental BiologyAngiogenesisGeneticsVascular MalformationMorphogenesis	1996	4.1K
Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo Karl H. Plate, Georg Breier, Herbert A. Weich, Nature Endothelial Cell PathobiologyNeuro-oncologyAngiogenesisPathologyHuman Gliomas	1992	2.3K
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis B Millauer, Susanne Wizigmann-Voos, Harald Schnürch, Cell Developmental BiologyAngiogenesisReceptor Tyrosine KinaseDevelopmental ExpressionMajor Regulator	1993	1.9K
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation Thomas T. Sato, Yuzuru Tozawa, Urban Deutsch, Nature Receptor TyrosineAngiogenesisSignal TransductionSignaling PathwayReceptor Tyrosine Kinase	1995	1.8K
Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation Georg Breier, Ursula Albrecht, S. Sterrer, Development Murine Vegf GeneCell DifferentiationEmbryonic AngiogenesisBrain AngiogenesisAngiogenesis	1992	1.1K
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. T. Annie T. Fong, Laura K. Shawver, Li Sun, PubMed Novel Synthetic CompoundChemoprevention StrategyPathologyTyrosine Kinase CatalysisTumor Biology	1999	1K
Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis Ralf H. Adams, George A. Wilkinson, Chana Weiss, Genes & Development	1999	1K
The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities Matthias Clauss, Herbert A. Weich, Georg Breier, Journal of Biological Chemistry	1996	840
Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor Fuyuki Ishikawa, Kohei Miyazono, Ulf Hellman, Nature ThrombopoiesisThrombosisAngiogenesisCardiovascular DiseaseBlood Platelet	1989	715
Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Marijke Fràter‐Schröder, Werner Risau, Rupert Hallmann, Proceedings of the National Academy of Sciences Vascular DiseasePotent InhibitorEndothelial Cell GrowthImmunologyPathology	1987	711

Page 1